阿司匹林用于一级预防：药物效应区域差异的重要性。 - Suppr

Suppr

超能文献

Aspirin for Primary Prevention: The Importance of the Regional Difference of Drug Effect.

作者信息

Watanabe Hirotoshi

机构信息

Division of Cardiology, Hirakata Kohsai Hospital, Hirakata, Japan.

出版信息

JACC Asia. 2023 Oct 3;3(6):863-864. doi: 10.1016/j.jacasi.2023.08.006. eCollection 2023 Dec.

DOI:10.1016/j.jacasi.2023.08.006

PMID:38155792

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10751637/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6db/10751637/8908b6304e63/ga1.jpg

相似文献

Aspirin for Primary Prevention: The Importance of the Regional Difference of Drug Effect.

JACC Asia. 2023 Oct 3;3(6):863-864. doi: 10.1016/j.jacasi.2023.08.006. eCollection 2023 Dec.

Low-Dose Aspirin for Primary Prevention of Cardiovascular Events Comparing East Asians With Westerners: A Meta-Analysis.

JACC Asia. 2023 Sep 12;3(6):846-862. doi: 10.1016/j.jacasi.2023.07.008. eCollection 2023 Dec.

Identifying opportunities to improve aspirin utilization for the primary prevention of cardiovascular disease in a regional health care system.

WMJ. 2014 Oct;113(5):190-5; quiz 196.

Dabigatran or Aspirin in East Asian Patients With Embolic Stroke of Undetermined Source: RE-SPECT ESUS Subgroup Analysis.

Stroke. 2021 Mar;52(3):1069-1073. doi: 10.1161/STROKEAHA.120.031891. Epub 2021 Feb 16.

A review and study of aspirin utilization for the primary prevention of cardiovascular events in a psychiatric population.

Int Clin Psychopharmacol. 2018 Sep;33(5):274-281. doi: 10.1097/YIC.0000000000000228.

Aspirin for Primary Prevention of Cardiovascular Disease.

J Lipid Atheroscler. 2019 Sep;8(2):162-172. doi: 10.12997/jla.2019.8.2.162. Epub 2019 Aug 22.

Low-dose aspirin and upper gastrointestinal bleeding in primary versus secondary cardiovascular prevention: a population-based, nested case-control study.

Circ Cardiovasc Qual Outcomes. 2014 Jan;7(1):70-7. doi: 10.1161/CIRCOUTCOMES.113.000494. Epub 2013 Nov 19.

Aspirin for Primary Prevention of Cardiovascular Disease in Diabetes: a Review of the Evidence.

Curr Diab Rep. 2019 Sep 23;19(10):107. doi: 10.1007/s11892-019-1206-6.

Usefulness of Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease.

Am J Cardiol. 2019 Dec 1;124(11):1785-1789. doi: 10.1016/j.amjcard.2019.08.040. Epub 2019 Sep 9.

Temporal trends in low-dose aspirin therapy for primary prevention of cardiovascular disease in European adults with and without diabetes.

Eur J Prev Cardiol. 2023 Sep 6;30(12):1172-1181. doi: 10.1093/eurjpc/zwad092.

引用本文的文献

Dual antiplatelet therapy in GI-bleed patients with extensive coronary artery disease history: a systematic review.

Ann Med Surg (Lond). 2025 Apr 25;87(6):3715-3735. doi: 10.1097/MS9.0000000000002833. eCollection 2025 Jun.

本文引用的文献

Low-Dose Aspirin for Primary Prevention of Cardiovascular Events Comparing East Asians With Westerners: A Meta-Analysis.

JACC Asia. 2023 Sep 12;3(6):846-862. doi: 10.1016/j.jacasi.2023.07.008. eCollection 2023 Dec.

Aspirin for Primary Prevention-Time to Rethink Our Approach.

JAMA Netw Open. 2022 Apr 1;5(4):e2210144. doi: 10.1001/jamanetworkopen.2022.10144.

2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

J Am Coll Cardiol. 2022 Jan 18;79(2):197-215. doi: 10.1016/j.jacc.2021.09.005. Epub 2021 Dec 9.

P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials.

BMJ. 2021 Jun 16;373:n1332. doi: 10.1136/bmj.n1332.

The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease.

Thromb Haemost. 2021 Apr;121(4):422-432. doi: 10.1055/s-0040-1718729. Epub 2020 Nov 10.

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.

Eur Heart J. 2021 Apr 7;42(14):1289-1367. doi: 10.1093/eurheartj/ehaa575.

JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery Disease.

Circ J. 2020 Apr 24;84(5):831-865. doi: 10.1253/circj.CJ-19-1109. Epub 2020 Mar 13.

Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial.

JAMA. 2019 Jun 25;321(24):2414-2427. doi: 10.1001/jama.2019.8145.

Racial Differences in Ischaemia/Bleeding Risk Trade-Off during Anti-Platelet Therapy: Individual Patient Level Landmark Meta-Analysis from Seven RCTs.

Thromb Haemost. 2019 Jan;119(1):149-162. doi: 10.1055/s-0038-1676545. Epub 2018 Dec 31.

Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.

N Engl J Med. 2018 Oct 18;379(16):1509-1518. doi: 10.1056/NEJMoa1805819. Epub 2018 Sep 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验